Ombrabulin (hydrochloride)
Ombrabulin hydrochloride is a derivative of CA-4 phosphate, which is known to exhibit antivascular effects through selective disruption of the tubulin cytoskeleton of endothelial cells.
Product Specifications
CAS Number
[253426-24-3]
Product Name Alternative
AVE8062 (hydrochloride) ; AC7700 (hydrochloride)
UNSPSC
12352005
Hazard Statement
H341, H351, H360, H362, H372
Target
Microtubule/Tubulin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Ombrabulin-hydrochloride.html
Purity
99.57
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 20 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)=CC=C1OC)[C@@H](N)CO.[H]Cl
Molecular Formula
C21H27ClN2O6
Molecular Weight
438.90
Precautions
H341, H351, H360, H362, H372
References & Citations
[1]Kim TJ, et al. Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res. 2007 Oct 1;67 (19) :9337-45.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Shigella boydii serotype 18 Glucokinase (glk)
Recombinant Shigella boydii serotype 18 Glucokinase (glk)
Recombinant Shigella boydii serotype 18 Glucokinase (glk)
Recombinant Shigella boydii serotype 18 Glucokinase (glk)
Recombinant Shigella boydii serotype 18 Glucokinase (glk)